Last updated on October 2018

A Study of the Safety Efficacy and Tolerability of Nexvax-2 in Patients With Celiac Disease (CeD)


Brief description of study

A randomized, double-blind, placebo-controlled clinical study in human leukocyte antigen (HLA)-DQ 2.5+ adults with celiac disease (CeD).

Detailed Study Description

A phase 2, randomized, double-blind, placebo-controlled clinical study of Nexvax2, in adults subjects with confirmed CeD who have been following a gluten free diet for at least 12 consecutive months prior to screening. This study will evaluate efficacy of Nexvax2 administered subcutaneously. The study plan consists of 3 periods: a screening period of 6 weeks, an approximately 16 week treatment period, and a 4 week post-treatment observational follow-up.

Clinical Study Identifier: NCT03644069

Contact Investigators or Research Sites near you

Start Over

Ronald Fogel

Clinical Research Institute of Michigan
Chesterfield, MI United States
  Connect »

John Weber

Center for Digestive Health
Troy, MI United States
  Connect »

Atoya Adams

AB Clinical Trials
Las Vegas, NV United States
  Connect »

Michael Goldstein

Long Island Gastrointestinal Research Group
Great Neck, NY United States
  Connect »

Michael Gerdis

Drug Trials America
Hartsdale, NY United States
  Connect »

Robert Holmes

PMG Research of Winston-Salem, LLC
Winston-Salem, NC United States
  Connect »

Scott Wilson

Ocean State Clinical Research Partners
Lincoln, RI United States
  Connect »

Helen Stacey

Diablo Clinical Research
Walnut Creek, CA United States
  Connect »

Kristin Neff

Connecticut Clinical Research Institute
Bristol, CT United States
  Connect »

David Radin

Stamford Therapeutics Consortium
Stamford, CT United States
  Connect »

Vipin Gupta

Alliance Medical Research
Lighthouse Point, FL United States
  Connect »

Clint Behrend

Grand Teton Research Group
Idaho Falls, ID United States
  Connect »

Kristin Neff

UCMC - Center for Clinical Cancer Genetics and Global Health
Chicago, IL United States
  Connect »

Bryan Feyen

PMG Research of McFarland Clinic
Ames, IA United States
  Connect »

Kristin Neff

University of Iowa
Iowa City, IA United States
  Connect »

Thomas Klein

Heartland Research Associates
Wichita, KS United States
  Connect »

Allan Coates

West Michigan Clinical Research Center
Wyoming, MI United States
  Connect »

Kristin Neff

Mayo Clinic
Rochester, MN United States
  Connect »

Roger Epstein

ActivMed Practices & Research
Portsmouth, NH United States
  Connect »

Kristin Neff

Celiac Disease Center at Columbia University
New York, NY United States
  Connect »

Vivek Trivedi

PMG Research of Piedmont Healthcare
Statesville, NC United States
  Connect »

Keith Friedenberg

Great Lakes Gastroenterology Research
Mentor, OH United States
  Connect »

Kristin Neff

Thomas Jefferson University Hospitals - Center City Campus
Philadelphia, PA United States
  Connect »

Eric Newton

Omega Medical Research
Warwick, RI United States
  Connect »

Cynthia Strout

Coastal Carolina Research
Mount Pleasant, SC United States
  Connect »

George James

Digestive Health Research
Hermitage, TN United States
  Connect »

Kristin Neff

Texas Digestive Disease Consultants
Southlake, TX United States
  Connect »

John Lowe

Advanced Research Institute
South Ogden, UT United States
  Connect »

Samuel Idarraga

Allegiance Research Specialists
Wauwatosa, WI United States
  Connect »